$PGY

Pagaya Technologies Posts Upbeat Q3 Results, Joins Ironwood Pharmaceuticals, TreeHouse Foods And Other Big Stocks Moving Higher On Monday - Cogent Biosciences (NASDAQ:COGT), e.l.f. Beauty (NYSE:ELF)

U.S. stocks were higher, with the Nasdaq Composite gaining more than 400 points on Monday. Shares of Pagaya Technologies Ltd ( NASDAQ:PGY ) rose sharply during Monday's session after the company reported better-than-expected third-quarter financial results and raised its FY25 sales guidance.

Original reporting
Benzinga · Avi Kapoor
Published Nov 10, 2025, 3:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 11, 2025, 1:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Pagaya Technologies Posts Upbeat Q3 Results, Joins Ironwood Pharmaceuticals, TreeHouse Foods And Other Big Stocks Moving Higher On Monday - Cogent Biosciences (NASDAQ:COGT), e.l.f. Beauty (NYSE:ELF) — source image
Decision brief

The 30-second read

$PGYBullishMed
01

Why it matters

The earnings beat and upward guidance from PGY have bolstered investor confidence, leading to increased buying activity and sector optimism.

02

Market read

The positive earnings reports and market rally suggest a favorable environment for growth stocks, especially in technology and life sciences sectors, with potential spill-over effects to related industries.

03

What to watch

Potential macroeconomic headwinds, interest rate changes, or sector-specific risks could impact stock performance despite positive earnings reports.

Timing: short-term to immediate

Background

The U.S. stock market experienced a rally with the Nasdaq gaining over 400 points, driven by strong earnings reports and positive guidance from key companies like Pagaya Technologies.

Company-level read

Ticker impact

$PGYBullishHigh confidence
Context

Primary focus due to recent strong earnings report and upward guidance.

Expected impact

Potential short-term upward movement; possible correction after initial surge. Long-term outlook remains cautiously optimistic if fundamentals sustain.

Evidence & confidence

Earnings beat estimates and guidance raise are strong fundamentals signals, supported by positive market reaction.

$COGTNeutralMedium confidence
Context

Moderate relevance; news may influence short-term trading but less impact on long-term fundamentals.

Expected impact

Likely sideways movement; technical analysis needed for precise levels.

Evidence & confidence

Absence of recent catalysts limits impact.

$IRWDBullishHigh confidence
Context

Somewhat-bullish; recent news supports positive outlook.

Expected impact

Potential upward trend in short term.

Evidence & confidence

Strong news and positive sentiment reinforce bullish outlook.

Market effects

The positive earnings reports and market rally suggest a favorable environment for growth stocks, particularly in technology and life sciences sectors.

U.S. stock market rally indicates strong regional investor confidence, potentially benefiting related sectors.

Moderate; U.S. market strength may influence global markets, especially in sectors with international exposure.

Counterpoint

While positive earnings have driven recent gains, broader economic uncertainties and potential market corrections could limit upside. Some stocks may be overextended and vulnerable to profit-taking.

Key entities

  • Pagaya Technologies Ltd

    A financial technology company specializing in AI-driven investment solutions.

  • Ironwood Pharmaceuticals

    A biopharmaceutical company focused on gastrointestinal therapies.

  • TreeHouse Foods

    A manufacturer of private label food products.

  • VFF

    Village Farms International, involved in sustainable agriculture and cannabis.

Related articles

$IRWDHigh

IRONWOOD PHARMACEUTICALS INC (IRWD): Results of Operations and Financial Condition

IRONWOOD PHARMACEUTICALS INC (IRWD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622244d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results – Raises full-year 2026 LINZESS ® (linaclotide) U.S. net sales guidance to $1.15 - $1.20 bi

$PGYHigh

Pagaya Technologies Ltd. (PGY): Results of Operations and Financial Condition

Pagaya Technologies Ltd. (PGY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 shareholderletter2q2026.htm EX-99.2 shareholderletter2q2026 Q1 Q2 Q3 Q4 Q2 Letter to Shareholders July 30, 2026 Q2 2026 Shareholder Letter 2 Q2 Financial Highlights $3.5B Network volume of $3.5 billion compared to our outlook of $2.875 - $3.075 billion and grew 33% year

$IRWDMed

Ironwood Appoints Dr. Jeffrey Silber As Chief Medical Officer; STARS-2 Trial Actively Recruiting

Ironwood Pharmaceuticals (IRWD) appointed Dr. Jeffrey Silber as Chief Medical Officer and Head of Research and Drug Development, effective July 20, 2026, replacing retiring Dr. Michael Shetzline, who will advise during transition. IRWD said its confirmatory Phase 3 STARS-2 trial of apraglutide for SBS-IF began in June and is actively recruiting. IRWD shares last traded at $4.08, down 3.09%.

$PGYMed

Pagaya (PGY) Closes Upsized $800 Million AAA Personal Loan ABS Deal

Pagaya Technologies (NASDAQ:PGY) said it closed an upsized $800 million AAA-rated personal loan ABS deal, PAID 2026-4, on June 15, 2026. The transaction involved 39 investors and brings YTD personal loan ABS issuance to nearly $4 billion, its third upsized deal this year. Pagaya reported $40 billion issued since 2018 across 91 ABS deals. Texas Capital initiated coverage June 10 with a Buy rating and $27 target.